Circulating adipocyte-derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypass

Obesity

Volumn 25, Issue 1, 2017, Pages 102-110

  Hubal, Monica J ^a   Nadler, Evan P ^a,b   Ferrante, Sarah C ^a   Barberio, Matthew D ^a   Suh, Jung Hyuk ^c   Wang, Justin ^a   Dohm, G Lynis ^d   Pories, Walter J ^d   Mietus Snyder, Michelle ^b   Freishtat, Robert J ^a,b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BETA CATENIN; BRANCHED CHAIN AMINO ACID; CORTICOTROPIN RELEASING FACTOR; FIBROBLAST GROWTH FACTOR; INSULIN RECEPTOR; MICRORNA; MICRORNA 122 5P; MICRORNA 126 3P; MICRORNA 155 5P; MICRORNA 199A 5P; MICRORNA 4664 5P; MICRORNA 4747 5P; MICRORNA 503 5P; MICRORNA 516B 5P; MICRORNA 539 5P; MICRORNA 874 5P; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN 14 3 3; SCATTER FACTOR; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; INSULIN;

ADIPOCYTE; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXOSOME; FEMALE; GASTRIC BYPASS SURGERY; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; AFRICAN AMERICAN; GENE EXPRESSION REGULATION; MALE; METABOLISM; MIDDLE AGED; OBESITY; PHYSIOLOGY;

ADIPOCYTES; ADULT; AFRICAN AMERICANS; AMINO ACIDS, BRANCHED-CHAIN; FEMALE; GASTRIC BYPASS; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MICRORNAS; MIDDLE AGED; OBESITY;

EID: 85008255614     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21709     Document Type: Article

References (39)

1. Boden G, Cheung P, Kresge K, Homko C, Powers B, Ferrer L. Insulin resistance is associated with diminished endoplasmic reticulum stress responses in adipose tissue of healthy and diabetic subjects. Diabetes 2014;63:2977-2983.
2. Kim JY, van de Wall E, Laplante M, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007;117:2621-2637.
3. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest 2011;121:2094-2101.
4. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-783.
5. Marette A, Liu Y, Sweeney G. Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome. Rev Endocr Metab Disord 2014;15:299-305.
6. Sam S, Mazzone T. Adipose tissue changes in obesity and the impact on metabolic function. Transl Res 2014;164:284-292.
7. Gomez-Ambrosi J, Silva C, Galofre JC, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) 2012;36:286-294.
8. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:367-377.
9. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014;371:1131-1141.
10. Deng ZB, Poliakov A, Hardy RW, et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 2009;58:2498-2505.
11. Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 2011;1:98-110.
12. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009;2:ra81. doi:10.1126/scisignal.2000610.
13. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-233.
14. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575.
15. Ferrante SC, Nadler EP, Pillai DK, et al. Adipocyte-derived exosomal miRNAs: a novel mechanism for obesity-related disease. Pediatr Res 2015;77:447-454.
16. Koeck ES, Iordanskaia T, Sevilla S, et al. Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease. J Surg Res 2014;192:268-275.
17. Schauer PR, Bhatt DL, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med 2014;371:682.
18. Shan T, Liu W, Kuang S. Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues. FASEB J 2013;27:277-287.
19. Suh JH, Kim R, Yavuz B, et al. Clinical assay of four thiol amino acid redox couples by LC-MS/MS: utility in thalassemia. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:3418-3427.
20. Suh JH, Kim RY, Lee DS. A new metabolomic assay to examine inflammation and redox pathways following LPS challenge. J Inflamm (Lond) 2012;9:37. doi:10.1186/1476-9255-9-37.
21. Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg 2014;24:1126-1135.
22. Dar M, Pories WJ. Bariatric surgery: what is the effect on type 2 diabetes? Curr Opin Invest Drugs 2009;10:1078-1084.
23. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-1737.
24. Inabnet WB III, Winegar DA, Sherif B, Sarr MG. Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg 2012;214:550-556; discussion 556-557.
25. Davalos A, Goedeke L, Smibert P, et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci USA 2011;108:9232-9237.
26. He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 2007;21:2785-2794.
27. Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA. miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol 2011;31:3182-3194.
28. Trajkovski M, Hausser J, Soutschek J, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011;474:649-653.
29. Rong Y, Bao W, Shan Z, et al. Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus. PLoS One 2013;8:e73272.
30. Zhang Q, Xiao X, Li M, et al. miR-375 and miR-30d in the effect of chromium-containing Chinese medicine moderating glucose metabolism. J Diabetes Res 2014;2014:862473.
31. Xu Q, Li Y, Shang YF, Wang HL, Yao MX. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease. World J Gastroenterol 2015;21:511-516.
32. Prabu P, Rome S, Sathishkumar C, et al. Circulating MiRNAs of ‘Asian Indian phenotype’ identified in subjects with impaired glucose tolerance and patients with type 2 diabetes. PLoS One 2015;10:e0128372.
33. Chuang TY, Wu HL, Chen CC, et al. MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue. J Diabetes Res 2015;2015:943659.
34. Vienberg S, Geiger J, Madsen S, Dalgaard LT. MicroRNAs in metabolism [published online ahead of print March 24, 2016]. Acta Physiol (Oxf) doi: 10.1111/apha.12681.
35. Cheng S, Rhee EP, Larson MG, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 2012;125:2222-2231.
36. Batch BC, Shah SH, Newgard CB, et al. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism 2013;62:961-969.
37. McCormack SE, Shaham O, McCarthy MA, et al. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes 2013;8:52-61.
38. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 2007;293:E1552-E1563.
39. Mittendorfer B, Volpi E, Wolfe RR. Whole body and skeletal muscle glutamine metabolism in healthy subjects. Am J Physiol Endocrinol Metab 2001;280:E323-E333.